全文获取类型
收费全文 | 24422篇 |
免费 | 2171篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 247篇 |
儿科学 | 923篇 |
妇产科学 | 828篇 |
基础医学 | 2977篇 |
口腔科学 | 311篇 |
临床医学 | 3215篇 |
内科学 | 4449篇 |
皮肤病学 | 531篇 |
神经病学 | 2378篇 |
特种医学 | 483篇 |
外科学 | 2559篇 |
综合类 | 250篇 |
一般理论 | 37篇 |
预防医学 | 3644篇 |
眼科学 | 303篇 |
药学 | 1527篇 |
中国医学 | 21篇 |
肿瘤学 | 1975篇 |
出版年
2023年 | 330篇 |
2022年 | 190篇 |
2021年 | 798篇 |
2020年 | 583篇 |
2019年 | 876篇 |
2018年 | 917篇 |
2017年 | 699篇 |
2016年 | 764篇 |
2015年 | 796篇 |
2014年 | 1089篇 |
2013年 | 1588篇 |
2012年 | 2141篇 |
2011年 | 2249篇 |
2010年 | 1247篇 |
2009年 | 1180篇 |
2008年 | 1667篇 |
2007年 | 1749篇 |
2006年 | 1600篇 |
2005年 | 1365篇 |
2004年 | 1197篇 |
2003年 | 1059篇 |
2002年 | 954篇 |
2001年 | 164篇 |
2000年 | 105篇 |
1999年 | 126篇 |
1998年 | 179篇 |
1997年 | 115篇 |
1996年 | 78篇 |
1995年 | 91篇 |
1994年 | 76篇 |
1993年 | 51篇 |
1992年 | 51篇 |
1991年 | 51篇 |
1990年 | 48篇 |
1989年 | 40篇 |
1988年 | 41篇 |
1987年 | 48篇 |
1986年 | 53篇 |
1985年 | 31篇 |
1984年 | 40篇 |
1983年 | 23篇 |
1982年 | 32篇 |
1981年 | 19篇 |
1980年 | 20篇 |
1979年 | 24篇 |
1978年 | 9篇 |
1977年 | 10篇 |
1974年 | 17篇 |
1973年 | 10篇 |
1971年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
Dermatophyte infections are exceedingly rare in neonates, possibly due to the thin stratum corneum and high sebum content of neonatal skin. Only a handful of cases of tinea faciei have been reported in neonates, with the majority of reports occuring in India. Here, we report what to our knowledge is the earliest reported presentation of tinea faciei in the United States. We also provide a brief literature review of other reported cases of tinea faciei in neonates less than 30 days of age. 相似文献
52.
53.
Lorna Hardy Katherine Josephy Amy McAndrew Phil Hawksley Lucie Hartley 《Addiction Research & Theory》2019,27(2):122-129
There is clear experimental evidence for a causal link between alcohol misuse and violent behaviour. Treatments for alcohol misuse with offenders are therefore justified on the grounds that they may reduce violent behaviour and thus re-offending. The current paper tested whether a 10-session CBT intervention with offenders still in prison would produce improvements across three time points (pre, post and follow up) in self-reported alcohol expectancies, aggressiveness, impulsivity, and self-efficacy in managing alcohol use and violent behaviour. The programme focussed on educating participants on the relationship between alcohol use and violence, modifying unhelpful cognitions, and providing skills based training to manage potential triggers. Data from 49 offenders in prison were collected pre-intervention, post-intervention, and at three month follow up. Long term improvements (from pre- to post-intervention and follow up) were observed with respect to alcohol expectancies (in terms of sociability and liquid courage), impulsive responding to negative affect triggers, trait anger, and confidence in managing alcohol use and offending behaviour. These findings provide preliminary evidence for the efficacy of the CBT programme in reducing harmful alcohol use and associated violence. Limitations and recommendations for future evaluation of the intervention are discussed. 相似文献
54.
55.
Mohid S Khan Thomas Walter Amy Buchanan-Hughes Emma Worthington Lucie Keeber Marion Feuilly Enrique Grande 《World journal of gastroenterology : WJG》2020,26(30):4537-4556
BACKGROUND Approximately 20% of patients with neuroendocrine tumours(NETs) develop carcinoid syndrome(CS),characterised by flushing and diarrhoea.Somatostatin analogues or telotristat can be used to control symptoms of CS through inhibition of serotonin secretion.Although CS is often the cause of diarrhoea among patients with gastroenteropancreatic NETs(GEP-NETs),other causes to consider include pancreatic enzyme insufficiency(PEI),bile acid malabsorption and small intestinal bacterial overgrowth.If other causes of diarrhoea unrelated to serotonin secretion are mistaken for CS diarrhoea,these treatments may be ineffective against the diarrhoea,risking detrimental effects to patient quality of life.AIM To identify and synthesise qualitative and quantitative evidence relating to the differential diagnosis of diarrhoea in patients with GEP-NETs.METHODS Electronic databases(MEDLINE,Embase and the Cochrane Library) were searched from inception to September 12,2018 using terms for NETs and diarrhoea.Congresses,systematic literature review bibliographies and included articles were also hand-searched.Any study designs and publication types were eligible for inclusion if relevant data on a cause(s) of diarrhoea in patients with GEP-NETs were reported.Studies were screened by two independent reviewers at abstract and full-text stages.Framework synthesis was adapted to synthesise quantitative and qualitative data.The definition of qualitative data was expanded to include all textual data in any section of relevant publications.RESULTS Forty-seven publications(44 studies) were included,comprising a variety of publication types,including observational studies,reviews,guidelines,case reports,interventional studies,and opinion pieces.Most reported on PEI on/after treatment with somatostatin analogs;9.5%-84% of patients with GEP-NETs had experienced steatorrhoea or confirmed PEI.Where reported,14.3%–50.7% of patients received pancreatic enzyme replacement therapy.Other causes of diarrhoea reported in patients with GEP-NETs included bile acid malabsorption(80%),small intestinal bacterial overgrowth(23.6%-62%),colitis(20%) and infection(7.1%).Diagnostic approaches included faecal elastase,breath tests,tauroselcholic(selenium-75) acid(Se HCAT) scan and stool culture,although evidence on the effectiveness or diagnostic accuracy of these approaches was limited.Assessment of patient history or diarrhoea characteristics was also reported as initial approaches for investigation.From the identified evidence,if diarrhoea is assumed to be CS diarrhoea,consequences include uncontrolled diarrhoea,malnutrition,and perceived ineffectiveness of CS treatment.Approaches for facilitating differential diagnosis of diarrhoea include improving patient and clinician awareness of non-CS causes and involvement of a multidisciplinary clinical team,including gastroenterologists.CONCLUSION Diarrhoea in GEP-NETs can be multifactorial with misdiagnosis leading to delayed patient recovery and inefficient resource use.This systematic literature review highlights gaps for further research on prevalence of non-CS diarrhoea and suitability of diagnostic approaches,to determine an effective algorithm for differential diagnosis of GEP-NET diarrhoea. 相似文献
56.
57.
58.
Rupa Narayan MD Traci M. Blonquist MS Ashkan Emadi MD PhD Robert P. Hasserjian MD Meghan Burke BS Christopher Lescinskas BS Donna S. Neuberg ScD Andrew M. Brunner MD Gabriela Hobbs MD Hanno Hock MD PhD Steven L. McAfee MD Yi-Bin Chen MD Eyal Attar MD Timothy A. Graubert MD Christina Bertoli MSN Jenna A. Moran MSN Meghan K. Bergeron MSN Julia E. Foster MSN Aura Y. Ramos BSN Tina T. Som BSN Megan K. Vartanian BSN RN Jennifer L. Story LPN Kristin McGregor MS Molly Macrae BS Tanya Behnan BS Margaret C. Wey PhD Jessica Rae BSN Frederic I. Preffer PhD Patricia Lesho BA Vu H. Duong MD Mason L. Mann BA Karen K. Ballen MD Christine Connolly BS Philip C. Amrein MD Amir T. Fathi MD 《Cancer》2020,126(6):1264-1273
59.
Amy L. Judd Kathryn L. Beck Christopher McKinlay Ashleigh Jackson Cathryn A. Conlon 《Maternal & child nutrition》2020,16(1)
Dietary assessment in infants is challenging but necessary to understand the relationship between nutrition and growth and development. Currently no simple, validated methods exist to assess nutrient intake in New Zealand (NZ) infants. Therefore, this study aimed to assess the relative validity and reproducibility of a Complementary Food Frequency Questionnaire (CFFQ) to determine nutrient intakes of NZ infants. Ninety‐five parent–infant pairs (infant age 10 ± 1 months) completed the CFFQ twice (CFFQ‐1 and CFFQ‐2), 4 weeks apart (to assess reproducibility). A 4‐day weighed food record (4dWFR) was collected between CFFQ administrations (to assess validity). Validity and reproducibility were assessed for intakes of energy and 18 nutrients using Bland–Altman analysis, Pearson's correlation coefficients, cross‐classification, and weighted Kappa (κ). The CFFQ showed acceptable validity: Nutrients from the CFFQ were comparable with the 4dWFR (bias, 9–28%), correlation between methods ranged from r = .18 (saturated fat) to r = .81 (iron; mean r = .52), 54% (mean) of participants were correctly classified (range 39% to 67%), and 7.1% (mean) misclassified into opposite tertiles (range 2.1% to 14.7%). There was acceptable agreement between the CFFQ and 4dWFR (κ = 0.20–0.60). The CFFQ showed good reproducibility: Correlations ranged from r = .34 (folate) to r = .80 (zinc); for 16 nutrients, >50% of participants were correctly classified, and for all nutrients, <10% of participants were grossly misclassified. All nutrients showed acceptable to good agreement (κ > 0.20). The CFFQ has acceptable relative validity and good reproducibility for assessing nutrient intake in NZ infants aged 9–12 months, making it a useful tool for use in future research. 相似文献
60.
Bhavana Pothuri Allison L. Brodsky Joseph A. Sparano Stephanie V. Blank Mimi Kim Dawn L. Hershman Amy Tiersten Brian F. Kiesel Jan H. Beumer Leonard Liebes Franco Muggia 《Cancer chemotherapy and pharmacology》2020,85(4):741-751
Poly(ADP-ribosyl) polymerases (PARPs) are nuclear enzymes with roles in DNA damage recognition and repair. PARP1 inhibition enhances the effects of DNA-damaging agents like doxorubicin. We sought to determine the recommended phase two dose (RP2D) of veliparib with pegylated liposomal doxorubicin (PLD) in breast and recurrent gynecologic cancer patients. Veliparib and PLD were administered in a standard phase 1, 3 + 3 dose-escalation design starting at 50 mg veliparib BID on days 1–14 with PLD 40 mg/mg2 on day 1 of a 28-day cycle. Dose escalation proceeded in two strata: A (prior PLD exposure) and B (no prior PLD exposure). Patients underwent limited pharmacokinetic (PK) sampling; an expansion PK cohort was added. 44 patients with recurrent ovarian or triple negative breast cancer were enrolled. Median age 56 years; 23 patients BRCA mutation carriers; median prior regimens four. Patients received a median of four cycles of veliparib/PLD. Grade 3/4 toxicities were observed in 10% of patients. Antitumor activity was observed in both sporadic and BRCA-deficient cancers. Two BRCA mutation carriers had complete responses. Two BRCA patients developed oral squamous cell cancers after completing this regimen. PLD exposure was observed to be higher when veliparib doses were > 200 mg BID. The RP2D is 200 mg veliparib BID on days 1–14 with 40 mg/m2 PLD on day 1 of a 28-day cycle. Anti-tumor activity was seen in both strata. However, given development of long-term squamous cell cancers and the PK interaction observed, efforts should focus on other targeted combinations to improve efficacy. 相似文献